Abstract | OBJECTIVE: METHODS: This retrospective study included 22 female patients with histologically confirmed HSIL and high-risk human papillomavirus (HR- HPV) infections. Patients were treated with ALA- PDT once a week for a total of 6 times. All patients had a follow-up period of 3 months and 6 months. The assessment of effectiveness of ALA- PDT was performed by ThinPrep cytology test (TCT), HPV DNA assay, HPV E6/E7 mRNA examination, colposcopy, biopsy, and immunohistochemistry detection. RESULTS: Three months after 5-ALA PDT, the histologic disappearance rate was 81.82% (18/22), while the HPV clearance rate was 54.55% (12/22). At the 6 months checkpoint, the HSIL disappearance rate was 90.91% (20/22) and the HPV clearance rate was 86.36% (19/22). Before PDT, 68.18% of patients (15/22) were confirmed with TCT abnormalities, while only one patient (1/22, 4.55%) was abnormal in the TCT test at 6 months checkpoint. All participants were found HPV E6/E7 mRNA positive initially, while the HPV E6/E7 mRNA negative rate was 90.91% (20/22) at 6 months checkpoint. Additionally, we found a significant difference of the expression of CD4+ and CD8+ T cells and HPV E6 and E7 proteins before ALA- PDT and at 3 months follow-up (P < 0.01). No severe side effects were seen. CONCLUSIONS: Topical 5-ALA PDT is an effective treatment for cervical HSIL with HR- HPV infection.
|
Authors | Yan Hu, Yu Li, Yanli Xu, Yincheng Teng, Jing Chen, Li Ma |
Journal | Photodiagnosis and photodynamic therapy
(Photodiagnosis Photodyn Ther)
Vol. 39
Pg. 103037
(Sep 2022)
ISSN: 1873-1597 [Electronic] Netherlands |
PMID | 35905829
(Publication Type: Journal Article)
|
Copyright | Copyright © 2022 The Author(s). Published by Elsevier B.V. All rights reserved. |
Chemical References |
- RNA, Messenger
- Aminolevulinic Acid
|
Topics |
- Aminolevulinic Acid
(therapeutic use)
- Female
- Humans
- Papillomaviridae
(genetics)
- Papillomavirus Infections
(diagnosis, drug therapy)
- Photochemotherapy
(methods)
- RNA, Messenger
(metabolism)
- Retrospective Studies
- Squamous Intraepithelial Lesions
- Uterine Cervical Neoplasms
(diagnosis)
- Uterine Cervical Dysplasia
(drug therapy)
|